CASI PHARMACEUTICALS, INC. Investing Cash Flow
CASI PHARMACEUTICALS, INC. (CASIF) reported Investing Cash Flow of $951.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-15
| Period end | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|
| 2025-12-31 | $951.00K 20-F · filed 2026-05-15 |
| 2024-12-31 | $11.24M 20-F · filed 2026-05-15 |
| 2023-12-31 | -$9.67M 20-F · filed 2026-05-15 |
| 2022-12-31 | $31.16M 20-F · filed 2025-03-31 |
| 2021-12-31 | -$20.69M 20-F · filed 2024-03-28 |
| 2020-12-31 | -$20.72M 20-F · filed 2023-04-26 |